• Philadelphia International Medicine

Chemotherapy-Induced ‘Dormancy’ in AML Allows Cancer Cell Survival, Contributing to Relapse

PHILADELPHIA (February 15, 2021) – Researchers at Fox Chase Cancer Center have helped to identify a cellular resilience mechanism through which acute myeloid leukemia (AML) cells survive cancer treatment and repopulate leukemia, causing disease relapse. The research also suggests that certain drugs could be used to destroy these treatment-surviving AML cells.